A Mathematical Explanation For Precision Of Trinucleotide Hereditary Diseases
Main Category: Biology / BiochemistryAlso Included In: Genetics
Article Date: 22 Nov 2007 - 17:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Scientists at the Weizmann Institute have proposed a mechanism which explains the precision of prognoses for trinucleotide repeat diseases. The study, published on November 23 in the journal PLoS Computational Biology, may lead researchers in the direction of a possible prevention or cure.
Based on the literature on some twenty known trinucleotide repeat diseases and their knowledge of the mechanisms governing somatic mutation, the team has proposed a mechanism that explains the precise relations between the patient's age of onset and the number of repeats in the diseased gene in the patient's genome. Using computer simulations and mathematical analysis of the mechanism the scientists have characterized the way in which the disease progresses.
Trinucleotide hereditary diseases are known as "time bomb" diseases, as people who live with them have a predictable onset of suffering and eventual death in adulthood. These diseases are caused by an unusual genetic mutation: A three-letter piece of gene code is repeated over and over in one gene. Scientists can predict by how many times the sequence repeats in a patient's gene both the age at which the disease will appear and how quickly the disease will progress.
The basic assumption has been that the protein fragment containing the amino acid (glutamine) encoded in the repeating triplet slowly builds up in the cells until eventually reaching toxic levels. This theory, unfortunately, fails to explain some of the clinical data.
The Weizmann Institute scientists, led by Ehud Shapiro, show that the answer lies in somatic mutations - changes in the number of DNA repeats that build up in our cells throughout our lives. The longer the DNA sequence, the greater the chance of additional mutation. The scientists realized that the genes carrying the disease code might be accumulating more and more DNA repeats over time, until some critical threshold is crossed.
These findings suggest that a cure for all might be found in a drug or treatment that slows down the expansion process, if researchers are successful in using this new model.
Citation: Kaplan S, Itzkovitz S, Shapiro E (2007) A universal mechanism ties genotype to phenotype in trinucleotide diseases. PLoS Comput Biol 3(11): e235. doi:10.1371/journal.pcbi.0030235
Please click here
Disclaimer
This press release refers to an upcoming article in PLoS Computational Biology. The release is provided by the article authors. Any opinions expressed in this release or article are the personal views of the journal staff and/or article contributors, and do not necessarily represent the views or policies of PLoS. PLoS expressly disclaims any and all warranties and liability in connection with the information found in the releases and articles and your use of such information.
About PLoS Computational Biology
PLoS Computational Biology features works of exceptional significance that further our understanding of living systems at all scales through the application of computational methods. All works published in PLoS Computational Biology are open access. Everything is immediately available subject only to the condition that the original authorship and source are properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License.
http://www.ploscompbiol.org
About the Public Library of Science The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource.
Public Library of Science
185 Berry Street, Suite 3100
San Francisco, CA 94107
USA
Visit our biology / biochemistry section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/89242.php>
APA
http://www.medicalnewstoday.com/releases/89242.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



